Filings

7 documents · 16 matches

1. AMLX Amylyx Pharmaceuticals, Inc. 10-Q 2026-11-05

   Item 1A. Risk Factors.

   material weaknesses in our internal controls over financial reporting. Any failure to maintain effective disclosure controls and internal control over
   3 matches in this document Show context Copy citation

2. AMLX Amylyx Pharmaceuticals, Inc. 10-Q 2026-08-06

   Item 1A. Risk Factors.

   material weaknesses in our internal controls over financial reporting. Any failure to maintain effective disclosure controls and internal control over
   3 matches in this document Show context Copy citation

3. AMLX Amylyx Pharmaceuticals, Inc. 10-Q 2026-05-07

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting. As a result of no longer qualifying as an emerging growth
   2 matches in this document Show context Copy citation

4. AMLX Amylyx Pharmaceuticals, Inc. 10-K 2026-03-03

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting. As a result of no longer qualifying as an emerging growth
   2 matches in this document Show context Copy citation

5. AMLX Amylyx Pharmaceuticals, Inc. 10-Q 2025-11-06

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting. As a result of no longer qualifying as an emerging growth
   2 matches in this document Show context Copy citation

6. AMLX Amylyx Pharmaceuticals, Inc. 10-Q 2025-08-07

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting. As a result of no longer qualifying as an emerging growth
   2 matches in this document Show context Copy citation

7. AMLX Amylyx Pharmaceuticals, Inc. 10-Q 2025-05-08

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting. As a result of no longer qualifying as an emerging growth
   2 matches in this document Show context Copy citation